Literature DB >> 18508914

Retrotranslocation of prion proteins from the endoplasmic reticulum by preventing GPI signal transamidation.

Aarthi Ashok1, Ramanujan S Hegde.   

Abstract

Neurodegeneration in diseases caused by altered metabolism of mammalian prion protein (PrP) can be averted by reducing PrP expression. To identify novel pathways for PrP down-regulation, we analyzed cells that had adapted to the negative selection pressure of stable overexpression of a disease-causing PrP mutant. A mutant cell line was isolated that selectively and quantitatively routes wild-type and various mutant PrPs for ER retrotranslocation and proteasomal degradation. Biochemical analyses of the mutant cells revealed that a defect in glycosylphosphatidylinositol (GPI) anchor synthesis leads to an unprocessed GPI-anchoring signal sequence that directs both ER retention and efficient retrotranslocation of PrP. An unprocessed GPI signal was sufficient to impart ER retention, but not retrotranslocation, to a heterologous protein, revealing an unexpected role for the mature domain in the metabolism of misprocessed GPI-anchored proteins. Our results provide new insights into the quality control pathways for unprocessed GPI-anchored proteins and identify transamidation of the GPI signal sequence as a step in PrP biosynthesis that is absolutely required for its surface expression. As each GPI signal sequence is unique, these results also identify signal recognition by the GPI-transamidase as a potential step for selective small molecule perturbation of PrP expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508914      PMCID: PMC2488287          DOI: 10.1091/mbc.e08-01-0087

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  90 in total

1.  Isolation and characterization of novel peroxisome biogenesis-defective Chinese hamster ovary cell mutants using green fluorescent protein.

Authors:  K Ghaedi; A Kawai; K Okumoto; S Tamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Exp Cell Res       Date:  1999-05-01       Impact factor: 3.905

2.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

3.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

4.  Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections.

Authors:  Erdmute Neuendorf; Artur Weber; Armin Saalmueller; Hermann Schatzl; Kurt Reifenberg; Eberhardt Pfaff; Martin Hermann Groschup
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

5.  Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.

Authors:  R Chiesa; P Piccardo; B Ghetti; D A Harris
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

6.  A somatic cell mutant defective in phosphatidylglycerophosphate synthase, with impaired phosphatidylglycerol and cardiolipin biosynthesis.

Authors:  T Ohtsuka; M Nishijima; Y Akamatsu
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

7.  PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology.

Authors:  J C Manson; A R Clarke; P A McBride; I McConnell; J Hope
Journal:  Neurodegeneration       Date:  1994-12

8.  Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal.

Authors:  M C Field; P Moran; W Li; G A Keller; I W Caras
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

Review 9.  The prion diseases.

Authors:  S B Prusiner
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

10.  Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies.

Authors:  S B Prusiner; D Groth; A Serban; R Koehler; D Foster; M Torchia; D Burton; S L Yang; S J DeArmond
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  27 in total

1.  The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein.

Authors:  Mauricio Torres; Danilo B Medinas; José Manuel Matamala; Ute Woehlbier; Víctor Hugo Cornejo; Tatiana Solda; Catherine Andreu; Pablo Rozas; Soledad Matus; Natalia Muñoz; Carmen Vergara; Luis Cartier; Claudio Soto; Maurizio Molinari; Claudio Hetz
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

Review 2.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 3.  RESETing ER proteostasis: selective stress pathway hidden in the secretory route.

Authors:  Andrés Couve; Claudio Hetz
Journal:  EMBO J       Date:  2014-09-04       Impact factor: 11.598

Review 4.  Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases.

Authors:  Berta Puig; Hermann C Altmeppen; Markus Glatzel
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

5.  Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma.

Authors:  Peng Zhao; Alison V Nairn; Shanterian Hester; Kelley W Moremen; Ruth M O'Regan; Gabriella Oprea; Lance Wells; Michael Pierce; Karen L Abbott
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

6.  Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps.

Authors:  Javier G Magadán; F Javier Pérez-Victoria; Rachid Sougrat; Yihong Ye; Klaus Strebel; Juan S Bonifacino
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

7.  Comparative Haploid Genetic Screens Reveal Divergent Pathways in the Biogenesis and Trafficking of Glycophosphatidylinositol-Anchored Proteins.

Authors:  Eric M Davis; Jihye Kim; Bridget L Menasche; Jacob Sheppard; Xuedong Liu; Aik-Choon Tan; Jingshi Shen
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

8.  Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.

Authors:  Yuzuru Taguchi; Arla M A Mistica; Tetsuyuki Kitamoto; Hermann M Schätzl
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

9.  Selective processing and metabolism of disease-causing mutant prion proteins.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

Review 10.  Prion neurotoxicity: insights from prion protein mutants.

Authors:  Isaac H Solomon; Jessie A Schepker; David A Harris
Journal:  Curr Issues Mol Biol       Date:  2009-09-18       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.